healthcare
Sebastien Beauzile Is Pain-Free After Lyfgenia While a $3.1 Million Sickle Cell Therapy Still Barely Reaches Patients
Health News
Marzo 14, 2025
Sebastien Beauzile Is Pain-Free After Lyfgenia While a $3.1 Million Sickle Cell Therapy Still Barely Reaches Patients
Sebastien Beauzile left sickle cell pain behind after Lyfgenia at Cohen Children's. Fewer than 40 patients have been infused, and the $3.1 million price still blocks the door.
Australian Man Lived 105 Days on a Titanium BiVACOR Heart That Was Still Only a Bridge to Someone Else’s Organ
News
Marzo 14, 2025
Australian Man Lived 105 Days on a Titanium BiVACOR Heart That Was Still Only a Bridge to Someone Else’s Organ
An unnamed Australian man went home with a magnetically levitated titanium heart for 105 days. Two later patients died of brain bleeds, and a commercial pump is still years off.
Dr. Elisabeth Potter Is Still Waiting After UnitedHealthcare’s Chief Promised Congress He Would Look
News
Gennaio 9, 2025
Dr. Elisabeth Potter Is Still Waiting After UnitedHealthcare’s Chief Promised Congress He Would Look
Dr. Elisabeth Potter says UnitedHealthcare called her mid-surgery. Her Austin center is still out of network after the company's chief told Congress he would look.
April Love Asked Police for a Hospital, Then Drove a Kia Through Inspira Bridgeton’s Ambulance Doors
Crimine News
Gennaio 1, 2025
April Love Asked Police for a Hospital, Then Drove a Kia Through Inspira Bridgeton’s Ambulance Doors
Police say April Love of New Castle drove about 60 feet into Inspira Bridgeton's ambulance hallway on New Year's Eve after declining a ride to the hospital earlier that night.
IDO1 Cancer Drugs Restarted Astrocyte Glucose In Alzheimer’s Models While Kisunla’s Cleared Plaques Held And England Still Haggles
Health News
Agosto 22, 2024
IDO1 Cancer Drugs Restarted Astrocyte Glucose In Alzheimer’s Models While Kisunla’s Cleared Plaques Held And England Still Haggles
Kisunla, approved in July 2024, can be stopped once amyloid plaques clear, and extension data showed most reductions holding for up to three years. IDO1 cancer inhibitors restored astrocyte glucose…